States are advancing healthcare legislation across three key areas as legislative sessions conclude. Multiple states enacted insurance reforms targeting utilization management and prior authorization, with Iowa, Utah, South Dakota, Washington, and New Mexico leading efforts. Indiana, Wyoming, and Utah passed Medicaid eligibility verification measures responding to federal reforms. Several states expanded scope of practice for pharmacists and mid-level providers to qualify for Rural Health Transformation Program funding.

Healthcare policy groups including FARB, NAIC, NAMD, NASHP, and NCOIL serve as platforms for state policymakers to collaborate and shape emerging trends. In 2025, multiple organizations adopted model legislation on facility fees and site-neutral payments, with NCOIL passing its Prior Authorization Reform Model Act in November. Groups are now focusing on the Rural Health Transformation Program and 340B oversight for 2026.

Virginia's Senate passed legislation to establish a Prescription Drug Affordability Board with upper payment limit authority, with similar House legislation pending under new Governor Abigail Spanberger. Four states currently have PDABs with UPL authority. Colorado became the first to set a UPL in October, effective January 2027, using Medicare's maximum fair price as the benchmark, though legal challenges remain ongoing.

Florida's Senate Committee on Health Policy voted 6-4 on January 29th to advance SB 1756, the Medical Freedom Act, which prohibits the State Health Officer from ordering vaccinations and establishes conscience protections as exemptions from school-entry vaccine requirements. The bill requires providers to obtain signed informed consent before administering vaccines to minors and awaits consideration in the Appropriations Committee.

Republican governors in Texas, Indiana, and Oklahoma are strengthening Medicaid oversight to combat fraud and abuse. Texas Governor Abbott directed reviews of high-risk services including autism care and enhanced managed care investigations. Indiana’s EO 26-04 established a Council on Fraud Detection and Prevention coordinating state agencies. Oklahoma’s EO 2026-02 mandates comprehensive welfare program reviews covering Medicaid, SNAP, and WIC, including fraud protocols and eligibility requirements.

Despite a December 2025 White House Executive Order threatening to cut BEAD Program funding for states with comprehensive AI oversight, nine states including Alabama, Hawaii, Indiana, Mississippi, Oklahoma, Rhode Island, Tennessee, Virginia, and Vermont have introduced 2026 legislation restricting insurers' use of AI in coverage decisions, with federal review expected by mid-March.

Congress passed comprehensive PBM reforms requiring 100% rebate pass-through to ERISA plans, detailed disclosure requirements, and Medicare Part D compensation limits to bona fide service fees. California and Colorado already adopted delinking practices, while New Jersey and Virginia introduced similar legislation. Ten states have introduced rebate pass-through bills, with federal transparency standards potentially becoming state-level requirements.

States enacted significant pharmacy benefit manager reforms in 2025, with Arkansas implementing the nation's first PBM-pharmacy ownership ban despite facing legal challenges. Massachusetts passed comprehensive licensing requirements, while Colorado and California adopted "delinking" laws prohibiting PBM compensation tied to drug prices. Utah mandated rebate pass-through mechanisms. These diverse approaches reflect growing bipartisan momentum toward curbing PBM practices affecting independent pharmacies and drug pricing transparency.

Following September 2025 federal restrictions limiting COVID-19 vaccine eligibility to adults 65+ and high-risk individuals, 18 states implemented protective measures including executive orders allowing pharmacy administration without prescriptions. Regional alliances like the West Coast Health Alliance and Northeast Public Health Collaborative emerged, while Florida moved to eliminate school vaccine mandates. The bipartisan Governor's Public Health Alliance launched October 15 with 15 governors coordinating responses.

Texas and Louisiana pursued legal action against out-of-state abortion providers while enacting laws allowing private citizens to sue those providing abortion medication. Six blue states responded with protective measures allowing facilities rather than individual clinicians on prescription labels. Emergency abortion clarifications passed in Arkansas, Kentucky, Tennessee, and Texas, while Colorado, New York, Washington, Massachusetts, and Connecticut codified federal emergency care protections into state law.

As federal vaccine recommendations become less consistent, states are increasingly asserting independent authority over immunization policies. Several states formed regional collaboratives for vaccine guidance and procurement in late 2025, while others enacted legislation replacing federal recommendations with state-based advisories. Conversely, some states like Florida are moving to eliminate school vaccine mandates and emphasize parental choice through regulatory changes.

Wyoming's Supreme Court overturned two 2023 abortion restriction laws, citing a 2012 constitutional amendment guaranteeing healthcare decision-making rights. The amendment, approved by 77 percent of voters as an anti-ACA measure, now protects abortion access under strict scrutiny standards. Similar healthcare freedom amendments in Ohio have challenged gender-affirming care bans and abortion restrictions, demonstrating unintended policy consequences.

Delaware legislators introduced SB 213 eliminating hospital budget oversight authority, while Florida faces court-ordered Medicaid termination pauses after constitutional violations. North Carolina's certificate of need laws face ongoing legal challenges, and New York Governor Hochul proposed $71 million in healthcare investments including mental health licensing reforms. Utah became the first state implementing AI prescription renewals for chronic conditions.

The Rural Health Transformation Program, created under the One Big Beautiful Bill Act, represents a $50 billion federal investment distributed as $10 billion annually from 2026-2030. All 50 states submitted applications in November requesting typically $1 billion each. CMS will announce awards by December 31, 2025, with half distributed equally among approved states and half awarded discretionally based on compelling initiatives and demonstrated need.

Colorado finalized the nation's first prescription drug upper payment limit, capping Enbrel at $600 per dose effective January 2027. Maryland conducted affordability reviews on four drugs and voted to set UPLs for Jardiance and Farxiga. Oregon reviewed 23 drugs with final recommendations expected March 2026, while Washington and Minnesota prepared for upcoming reviews.

Fifteen governors launched a public health alliance to improve emergency preparedness and coordination across state lines, while CMS announced all 50 states applied for the $50 billion Rural Health Transformation Program. California enacted major healthcare transparency and PBM oversight legislation, Colorado proposed significant Medicaid spending cuts, and Massachusetts advanced prior authorization reforms.

Amgen filed a second lawsuit against Colorado's Prescription Drug Affordability Board in October, challenging the board's authority to set upper payment limits after it established a $600 per unit limit on Enbrel based on Medicare pricing. The manufacturer argues the limits violate federal patent laws and due process, with the case potentially influencing similar drug pricing policies in Maryland, Minnesota, and Washington.

The National Council of Insurance Legislators adopted the Prior Authorization Reform Model Act and advanced artificial intelligence oversight policies at its Atlanta annual meeting. The Health Insurance Committee addressed charity care screening requirements and medical debt protections, while the Financial Services Committee continued developing AI governance standards requiring human professionals to make claim denial decisions. Legislators discussed expiring ACA tax credits' impact on market stability with state insurance commissioners.

Twenty-five states now require insurance coverage for fertility care as federal officials create new employer benefit pathways and negotiate lower drug prices. California delayed implementation of comprehensive IVF coverage mandates until 2026, while Virginia's commission drafted legislation requiring three IVF cycles in benchmark plans. Arkansas became the first state enacting restorative reproductive medicine legislation, though Nevada's governor vetoed broader Medicaid fertility coverage citing fiscal concerns.

States enacted significant pharmacy benefit manager reforms in 2025, including Arkansas's historic pharmacy ownership ban, Massachusetts's comprehensive licensing requirements, and Colorado/California's compensation delinking laws.